252 related articles for article (PubMed ID: 26117152)
1. Deoxynivalenol (DON) naturally contaminated feed impairs the immune response induced by porcine reproductive and respiratory syndrome virus (PRRSV) live attenuated vaccine.
Savard C; Gagnon CA; Chorfi Y
Vaccine; 2015 Jul; 33(32):3881-6. PubMed ID: 26117152
[TBL] [Abstract][Full Text] [Related]
2. In vivo effect of deoxynivalenol (DON) naturally contaminated feed on porcine reproductive and respiratory syndrome virus (PRRSV) infection.
Savard C; Pinilla V; Provost C; Gagnon CA; Chorfi Y
Vet Microbiol; 2014 Dec; 174(3-4):419-426. PubMed ID: 25465662
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
7. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
[TBL] [Abstract][Full Text] [Related]
8. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
[TBL] [Abstract][Full Text] [Related]
9. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
10. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
[TBL] [Abstract][Full Text] [Related]
11. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
12. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative effect of a microbial feed additive on infectious bronchitis virus antibody titer and stress index in broiler chicks fed deoxynivalenol.
Ghareeb K; Awad WA; Böhm J
Poult Sci; 2012 Apr; 91(4):800-7. PubMed ID: 22399717
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
[TBL] [Abstract][Full Text] [Related]
17. Influence of deoxynivalenol-contaminated feed on the immune response of pigs after PRRSV vaccination and infection.
Pierron A; Vatzia E; Stadler M; Mair KH; Schmidt S; Stas MR; Dürlinger S; Kreutzmann H; Knecht C; Balka G; Lagler J; Zaruba M; Rümenapf T; Saalmüller A; Mayer E; Ladinig A; Gerner W
Arch Toxicol; 2023 Apr; 97(4):1079-1089. PubMed ID: 36781434
[TBL] [Abstract][Full Text] [Related]
18. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
19. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
